Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Sotera Health ( (SHC) ) is now available.
Sotera Health Company held its 2026 annual meeting of stockholders on May 21, 2026, where shareholders elected all four Class III director nominees to three-year terms ending at the 2029 annual meeting. Investors also approved on an advisory basis the compensation of the company’s named executive officers and ratified Ernst & Young LLP as independent auditor for the fiscal year ending Dec. 31, 2026, signaling broad shareholder support for the current leadership and governance structure.
The director election results showed strong backing for the board slate, with each nominee receiving substantial majorities of votes cast despite some withheld votes for one candidate. The advisory say-on-pay approval and auditor ratification further underscore stockholder confidence in Sotera Health’s executive pay practices, financial oversight, and strategic direction heading into the 2026 fiscal year.
The most recent analyst rating on (SHC) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Sotera Health stock, see the SHC Stock Forecast page.
Spark’s Take on SHC Stock
According to Spark, TipRanks’ AI Analyst, SHC is a Neutral.
Overall score reflects improving operating performance and a constructive outlook (reaffirmed guidance, margin expansion, liquidity and leverage improvement), but is held back by high leverage/weak balance-sheet resilience and inconsistent free-cash-flow conversion. Technical signals are neutral and valuation (P/E ~38) is a further headwind without dividend support.
To see Spark’s full report on SHC stock, click here.
More about Sotera Health
Sotera Health Company operates in the healthcare services and life sciences sector, providing sterilization, lab testing, and related analytical services that support medical device, pharmaceutical, and food safety markets. The company focuses on ensuring the safety and effectiveness of products across highly regulated industries, positioning itself as a critical partner in global health supply chains.
Average Trading Volume: 3,573,672
Technical Sentiment Signal: Buy
Current Market Cap: $4.43B
See more data about SHC stock on TipRanks’ Stock Analysis page.